Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab (R-InO) versus chemotherapy for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL) Meeting Abstract
| Authors: | Dang, N. H.; Ogura, M.; Castaigne, S.; Fayad, L.; Jerkeman, M.; Radford, J. A.; Pezzutto, A.; Bondarenko, I.; Stewart, D. A.; Shnaidman, M.; Sullivan, S.; Vandendries, E.; Tobinai, K.; Ramchandren, R.; Hamlin, P. A.; Gine, E.; Ando, K. |
| Abstract Title: | Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab (R-InO) versus chemotherapy for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (B-NHL) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204209 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.8529 |
| Notes: | Meeting Abstract: 8529 -- Source: Wos |
